AI Science Tracker
EN

Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China

1 discovery from 2022

Discoveries

In Silico Identification of Key Genes and Immune Infiltration Characteristics in Epicardial Adipose Tissue from Patients with Coronary Artery Disease

Source check: Source checked. Not independent scientific confirmation.

Finding: LASSO and SVM-RFE selected TCF21, CDH19, XG and NNAT as coronary-artery-disease-associated genes in epicardial adipose-tissue expression data; associations were checked in two additional GEO datasets. Immune-cell estimates are computational, and no experimental perturbation validates the proposed biology.

Technology: LASSO and SVM-RFE select coronary-disease feature genes from expression datasets; CIBERSORT estimates immune-cell infiltration.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LASSO and SVM-RFE select coronary-disease feature genes from expression datasets; CIBERSORT estimates immune-cell infiltration.
Test and result
LASSO and SVM-RFE selected TCF21, CDH19, XG and NNAT as coronary-artery-disease-associated genes in epicardial adipose-tissue expression data; associations were checked in two additional GEO datasets
Limitation / still unknown
Immune-cell estimates are computational, and no experimental perturbation validates the proposed biology.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9637040/ · https://pubmed.ncbi.nlm.nih.gov/36345357/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.